FDA inspection
Lumis Global Pharmaceuticals Co. Ltd.: FDA inspection ending Sep 28, 2016
FDA inspection 988256 · Official Action Indicated (OAI) · Wuhan
Key facts
| Inspection ID | 988256 |
|---|---|
| Firm | Lumis Global Pharmaceuticals Co. Ltd. |
| FEI number | 3010280514 |
| Address | Huishang Mansion Unit 305, 2 Wudayuan Rd Donghu Ntdz |
| City | Wuhan |
| Country | China |
| Fiscal year | 2016 |
| Inspection end date | Sep 28, 2016 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 516043 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data